Moreover, when WHO grade (Supplementary Figure S3E), IDH status (Supplementary Figure S3F) and 1p/19q status (Supplementary Figure S3G) were added as sub-classifiers, the reactive astrocyte scores of recurrent glioma samples were significantly higher than those of primary glioma samples in the same subset. This evidence concerns the gene IDH1 and central nervous system cancer.